Selonterra Awarded US$2,500,000 Grant from The Michael J. Fox Foundation for Parkinson’s Research

SAN MATEO, Calif., March 8, 2023 /PRNewswire/ -- Selonterra, Inc. (www.selonterra.com), a biotechnology company developing transformative therapies for neurodegenerative disorders announces a grant award of US$2,500,000 from The Michael J. Fox Foundation for Parkinson's Research (MJFF)....

Click to view original post